Evidence map›Paper›PMID 29531546›Full record

ArticleIranian journal of pathology2017

High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer.

Azadeh-Sadat Nazouri, Ommolbanin Asadpour, Shahriar Dabiri, Bahram Pourseyedi, Mohamad Reaza Lashkarizadeh, Hamid Zianalinejad

Open access · goldAbstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Azadeh-Sadat NazouriDept. of Biology, Science Faculty, Shahid Beheshti University, Tehran, Iran.
Ommolbanin AsadpourDept. of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Shahriar DabiriPathology and Stem Cell Research Center, Pathology Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Bahram PourseyediSurgery Department, Kerman University of Medical Sciences, Kerman, Iran.
Mohamad Reaza LashkarizadehSurgery Department, Kerman University of Medical Sciences, Kerman, Iran.
Hamid ZianalinejadSurgery Department, Kerman University of Medical Sciences, Kerman, Iran.
Kerman University of Medical Sciences · IRShahid Beheshti University · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectiveBreast cancer is the leading cause of cancer related death in females. Sphingosine kinase 1 (SPHK1) and its product sphingosine-1-phosphate (S1P) are the essential key regulator molecules in breast cancer through their ability to promote cell proliferation, angiogenesis, cell proliferation, and lymphagiogenesis.

methodsA total of 120 human breast cancer tissue specimens were analyzed for

resultThe current study findings showed that the level of

conclusionThe current study showed that expression of

Indexed as

Breast CancerEstrogen and ProgesteronePhosphateReal–time PCRReceptorsSphingosine Kinase

Identifiers

PMID29531546
PMCPMC5835369
OpenAlexW2744187845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.